TBZ2833
Topotecan;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-, hydrochloride, (S);9-Dimethylaminomethyl-10-hydroxycamptothecin, HCl salt;Hycamptamine;(S)-Topotecan;SKF104864;Topotecan hydrochloride hydrate;9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin hydrochloride hydrate;Topotecan Hydrochloride(TPT);4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione hydrochloride;9-Dimethylaminomethyl-10-hydroxycamptothecin hydrochloride salt;Hycam;4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;9-Dimethylaminomethyl-10-hydroxycamptothecin;Hycamptin;nogitecan;NSC 609699;SKF-104864A;SKF-S 104864;HYDROCHLORIDE;MURIATIC ACID;SKF 104864
C23H23N3O5
421.45